Lead Clinical Scientist - Early Development

Genentech; South San Francisco (CA); On-site; USD 141,000 - 262,000; Full time

Benefits offered by this job

Discretionary bonus

Job summary

Genentech is seeking a Lead Clinical Scientist on the South San Francisco campus to drive early development strategies and oversee the Clinical Development Plan for one or more molecules. The role requires an advanced clinical degree and 4+ years in pharma/biotech, including cross-functional protocol authoring and data interpretation.

You will work onsite at South San Francisco, contribute to regulatory interactions, and support study start-up activities while partnering with cross-functional

Qualifications

• Advanced clinical/science degree preferred (PharmD, PhD, MSN, MPH, etc.).
• 4+ years pharma/biotech industry experience preferred.
• Experience in complex matrixed settings.
• Experience with cross-functional authoring full clinical trial protocols.
• In-depth understanding of drug development.
• Experience with data analysis, interpretation, and assessment of clinical relevance.

Responsibilities

• Contributes as a standing member of the Clinical Science Sub-Team.
• Drives authoring, review and team decisions to develop study protocols, ICFs, and study start-up documents.
• Conducts medical data review.
• Reviews protocol deviations.
• Primary POC for protocol-related inquiries from internal colleagues and external sites.
• Collaborates cross-functionally to present study data.

Skills

Clinical trial design

Data analysis

Cross-functional collaboration

Scientific writing

Education

Advanced degree (PharmD/PhD/MSN/MPH)

Job description

Genentech is seeking a Lead Clinical Scientist on the South San Francisco campus to drive early development strategies and oversee the Clinical Development Plan for one or more molecules. The role requires an advanced clinical degree and 4+ years in pharma/biotech, including cross-functional protocol authoring and data interpretation.

You will work onsite at South San Francisco, contribute to regulatory interactions, and support study start-up activities while partnering with cross-functional